Tolerogenic dendritic cell-based treatment for multiple sclerosis (MS): a harmonised study protocol for two phase I clinical trials comparing intradermal and intranodal cell administration
about
Tolerogenic dendritic cell-based treatment for multiple sclerosis (MS): a harmonised study protocol for two phase I clinical trials comparing intradermal and intranodal cell administration
description
scientific article published on 09 September 2019
@en
name
Tolerogenic dendritic cell-bas ...... intranodal cell administration
@en
type
label
Tolerogenic dendritic cell-bas ...... intranodal cell administration
@en
prefLabel
Tolerogenic dendritic cell-bas ...... intranodal cell administration
@en
P2093
P50
P1433
P1476
Tolerogenic dendritic cell-bas ...... intranodal cell administration
@en
P2093
Aina Teniente-Serra
Ana Maria Barriocanal
Anja Ten Brinke
Anna Massuet-Vilamajó
Annemie Ribbens
Ascensión Lopez-Diaz de Cerio
Bibiana Quirant-Sánchez
Cristina Ramo-Tello
Eva Martínez-Cáceres
P304
P356
10.1136/BMJOPEN-2019-030309
P577
2019-09-09T00:00:00Z